Loading stock data…
FUL
$62.03+2.00 (+3.33%)
After Hours$63.24+1.21 (+1.95%)· Last close Jun 9
H.B.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
H.B. Fuller Company in the Basic Materials sector is trading at $62.03 with a market capitalization of $3.4B. Wall Street consensus targets $70.43 (7 analysts), implying a +13.5% move over the next 12 months. The stock is currently 10% below its 52-week high of $68.63, remaining 3.4% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +13.5% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$62.03
Potential Upside
12.1%
Whystock Fair Value$69.51
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus7 analysts
Buy
Mean target$70.43+13.5%
Range$58.00 – $84.00
Fundamentals
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, He...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.35B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
21.29
Beta
Defensive asset. Lower volatility than the S&P 500.
0.94
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.56%
ROE
Average efficiency. Growth may require heavy reinvestment.
7.74%
Volume
Today's trading volume
648,075
Recent News
How The Investment Story For H.B. Fuller (FUL) Is Evolving Without New Analyst Input
H.B. Fuller’s latest analyst update comes with no change to the existing price target, keeping expectations steady for now. Even without fresh commentary driving that decision, the unchanged target still gives you a reference point for how the stock is being framed today. Read on to see how to track these kinds of updates and follow the evolving narrative around H.B. Fuller over time. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways...
FUL Expands Sustainable Packaging Portfolio With VerdaFresh
H.B. Fuller invests in VerdaFresh to boost recyclable packaging, helping cut waste and lower material use and carbon impact.
Is H. B. Fuller (FUL) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CSW Industrials (CSW) Surpasses Q4 Earnings and Revenue Estimates
CSW Industrials (CSW) delivered earnings and revenue surprises of +29.22% and +6.88%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
HB Fuller said to propose 285 pence per share deal for Advanced Medical Solutions
Investing.com -- H.B. Fuller Company (NYSE:FUL) has submitted an all-cash proposal to acquire Advanced Medical Solutions Group (LON:AMSU) for 285 pence per share, according to a source familiar with the matter. The news follows official disclosures Thursday from both companies confirming they are currently engaged in ongoing discussions and due diligence.